Michael Dale

Michael Dale

DirectoratAxogen· In proxies 2022–2025

Pay in FY2025+2% from the year before · Axogen stock +98.6% the same year

Michael Dale was paid $9.0M in FY2025 (Dec), up 2%. Axogen stock rose 98.6% that year.

Pay$100 in the stock at the end of FY21 → $349
Pay is from the Summary Compensation Table of each Axogen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CVRxPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  2. AxogenPublic company · 4 yr
    • CEO and President2022 – Present · 4 yrStock in role +406%
  3. BiomimedX, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. NeoChord, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Neuronetics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Preceptis Medical, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Preceptis Medical, Inc., GI Dynamics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. Rhythmia Medical, Inc., ATS Medical, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?